• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

作者信息

Raine Tim, Bonovas Stefanos, Burisch Johan, Kucharzik Torsten, Adamina Michel, Annese Vito, Bachmann Oliver, Bettenworth Dominik, Chaparro Maria, Czuber-Dochan Wladyslawa, Eder Piotr, Ellul Pierre, Fidalgo Catarina, Fiorino Gionata, Gionchetti Paolo, Gisbert Javier P, Gordon Hannah, Hedin Charlotte, Holubar Stefan, Iacucci Marietta, Karmiris Konstantinos, Katsanos Konstantinos, Kopylov Uri, Lakatos Peter L, Lytras Theodore, Lyutakov Ivan, Noor Nurulamin, Pellino Gianluca, Piovani Daniele, Savarino Edoardo, Selvaggi Francesco, Verstockt Bram, Spinelli Antonino, Panis Yves, Doherty Glen

机构信息

Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Department of Biomedical Sciences, Humanitas University; IRCCS Humanitas Research Hospital, Milan, Italy.

出版信息

J Crohns Colitis. 2022 Jan 28;16(1):2-17. doi: 10.1093/ecco-jcc/jjab178.

DOI:10.1093/ecco-jcc/jjab178
PMID:34635919
Abstract
摘要

相似文献

1
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.欧洲克罗恩病和结肠炎组织（ECCO）溃疡性结肠炎治疗指南：药物治疗
J Crohns Colitis. 2022 Jan 28;16(1):2-17. doi: 10.1093/ecco-jcc/jjab178.
2
Randomized controlled clinical trials in mild-moderate ulcerative colitis.轻中度溃疡性结肠炎的随机对照临床试验。
Rev Recent Clin Trials. 2012 Nov;7(4):256-69. doi: 10.2174/1574887111207040256.
3
Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.根据2011年欧洲克罗恩病和结肠炎组织（ECCO）-欧洲儿科胃肠病、肝病和营养学会（ESPGHAN）指南管理儿童急性重症溃疡性结肠炎：英夫利昔单抗作为挽救治疗的疗效
Dig Liver Dis. 2015 Jun;47(6):455-9. doi: 10.1016/j.dld.2015.01.156. Epub 2015 Feb 4.
4
Review article: medical treatment of severe ulcerative colitis.综述文章：重度溃疡性结肠炎的医学治疗
Aliment Pharmacol Ther. 2002 Jul;16 Suppl 4:7-12. doi: 10.1046/j.1365-2036.16.s4.2.x.
5
Medical treatment and management of severe ulcerative colitis.重度溃疡性结肠炎的医学治疗与管理
Dig Liver Dis. 2008 Jul;40 Suppl 2:S280-4. doi: 10.1016/S1590-8658(08)60538-1.
6
Ulcerative colitis practice guidelines in adults.成人溃疡性结肠炎实践指南
Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):10-2. doi: 10.1016/j.clinre.2011.09.013. Epub 2011 Dec 3.
7
[Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU].[溃疡性结肠炎治疗指南：GETECCU基于GRADE方法学的工作成果]
Gastroenterol Hepatol. 2013 Oct;36(8):e1-47. doi: 10.1016/j.gastrohep.2012.11.001.
8
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.2011年欧洲和澳大利亚炎症性肠病的发病率及疾病初发病程：2011年欧洲克罗恩病和结肠炎组织-炎症性肠病流行病学监测初始队列研究结果
J Crohns Colitis. 2014 Nov;8(11):1506-15. doi: 10.1016/j.crohns.2014.06.004. Epub 2014 Jul 4.
9
[Treatment of active ulcerative colitis].[活动性溃疡性结肠炎的治疗]
Gastroenterol Hepatol. 1996 Jan;19(1):24-6.
10
Ulcerative Colitis: Update on Medical Management.溃疡性结肠炎：药物治疗的最新进展
Curr Gastroenterol Rep. 2015 Nov;17(11):44. doi: 10.1007/s11894-015-0466-9.

引用本文的文献

1
Therapeutic potential of alpha-lipoic acid on mitochondrial dynamics, oxidative/nitrosative stress, and histopathological changes in rat ulcerative colitis model.α-硫辛酸对大鼠溃疡性结肠炎模型线粒体动力学、氧化/亚硝化应激及组织病理学变化的治疗潜力
Inflammopharmacology. 2025 Sep 1. doi: 10.1007/s10787-025-01918-4.
2
Lifestyle and psychosocial factors in inflammatory bowel disease: Prevalence, impact, motivation, and support needs.炎症性肠病中的生活方式和社会心理因素：患病率、影响、动机及支持需求
PLoS One. 2025 Aug 29;20(8):e0331092. doi: 10.1371/journal.pone.0331092. eCollection 2025.
3
Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023.
2017年至2023年加泰罗尼亚地区基于人群的登记处关于炎症性肠病的患病率、发病率、死亡率及治疗趋势的最新情况
J Clin Med. 2025 Aug 12;14(16):5711. doi: 10.3390/jcm14165711.
4
Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease.检测TPMT和NUDT15*3变体以预测意大利炎症性肠病患者队列对硫嘌呤类药物的反应。
Int J Mol Sci. 2025 Aug 14;26(16):7860. doi: 10.3390/ijms26167860.
5
Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study.深度缓解是IBD中降低生物治疗强度的合适时机吗？一项单中心回顾性研究。
Biomedicines. 2025 Aug 7;13(8):1928. doi: 10.3390/biomedicines13081928.
6
Mesoporous nanomaterial-based smart nanoplatforms for precise therapies of ulcerative colitis: Strategies and challenges.用于溃疡性结肠炎精准治疗的介孔纳米材料基智能纳米平台：策略与挑战
Theranostics. 2025 Jul 11;15(15):7872-7901. doi: 10.7150/thno.109268. eCollection 2025.
7
Self-Injection Satisfaction and Safety of CT-P17 (Yuflyma), a High-Concentration Adalimumab Biosimilar, in Patients With Crohn's Disease: A Cross-Sectional Study.高浓度阿达木单抗生物类似药CT-P17（Yuflyma）在克罗恩病患者中的自我注射满意度及安全性：一项横断面研究
JGH Open. 2025 Jul 28;9(8):e70230. doi: 10.1002/jgh3.70230. eCollection 2025 Aug.
8
in Ulcerative Colitis: Analysis of Clinical Findings and Biochemical Parameters.溃疡性结肠炎：临床发现与生化参数分析
Pathogens. 2025 Jul 9;14(7):674. doi: 10.3390/pathogens14070674.
9
Characteristics and Clinical Implications of Cytomegalovirus Infection in Patients with Drug-Resistant Ulcerative Colitis Undergoing Colectomy-Data from a Tertiary Referral Center in Poland.波兰一家三级转诊中心的数据：接受结肠切除术的耐药性溃疡性结肠炎患者巨细胞病毒感染的特征及临床意义
J Clin Med. 2025 Jul 8;14(14):4823. doi: 10.3390/jcm14144823.
10
Colectomy and Neoplasia Outcomes of Patients With Ulcerative Colitis Receiving Golimumab: A Post-Authorisation Safety Study Using the Spanish ENEIDA Registry.接受戈利木单抗治疗的溃疡性结肠炎患者的结肠切除术及肿瘤转归：一项使用西班牙ENEIDA注册库的上市后安全性研究
Pharmacoepidemiol Drug Saf. 2025 Aug;34(8):e70176. doi: 10.1002/pds.70176.